NCT04262791 A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD) Status TERMINATED Phase PHASE1
NCT04256174 A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT04250350 Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04250337 Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. Status COMPLETED Phase PHASE3
NCT04240522 Prospective Longitudinal Observational Research in Atopic Dermatitis Status RECRUITING Phase N/A
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04214197 Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis Status UNKNOWN Phase PHASE4
NCT04212169 Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04211415 Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT04195698 Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04193670 Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis Status COMPLETED Phase NA
NCT04192513 Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo Status TERMINATED Phase PHASE2
NCT04178967 Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3